section name header

Indications

BEERS REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension, tachycardia

Derm: flushing, rash

GI: epigastric distress, hiccups, nausea, vomiting

Hemat: eosinophilia, leukopenia

Neuro: dizziness, drowsiness, agitation, ataxia, depression, headache, insomnia, irritability, syncope

Resp: asthma attacks

Misc: ANAPHYLACTIC SHOCK, fever, psychological dependence

Interactions

Drug-drug:

Drug-Natural Products:

Availability

(Generic available)

Route/Dosage

US Brand Names

Soma

Action

  • Skeletal muscle relaxation, probably due to CNS depression.
Therapeutic effects:
  • Skeletal muscle relaxation.

Classifications

Therapeutic Classification: skeletal muscle relaxants (centrally acting)

Pharmacokinetics

Absorption: Well absorbed after oral administration.

Distribution: Crosses the placenta; high concentrations in breast milk.

Metabolism/Excretion: Mostly metabolized by the liver via the CYP2C19 isoenzyme to meprobamate; the CYP2C19 enzyme system exhibits genetic polymorphism (2% of Whites, 4% of Blacks, and 14% of Asians may be poor metabolizers and may have significantly carisoprodol concentrations and an risk of adverse effects). Excreted by both renal and non-renal pathways. .

Half-Life: Carisoprodol: 2 hr; meprobamate: 10 hr.

Contr. Subst. Schedule

Schedule IV (C-IV)

Time/Action Profile

(skeletal muscle relaxation)

ROUTEONSETPEAKDURATION
PO30 minunknown4–6 hr

Patient/Family Teaching

Pronunciation

kar-i-SOP-roe-dole

Pill Image

carisoprodol_195-8712.jpg

Code

NDC Code